Capital Fund Management (CFM)
VIR icon

Capital Fund Management (CFM)’s Vir Biotechnology VIR Stock Holding History

Capital Fund Management (CFM)’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-29,260
Closed -$718K – 2109
2023
Q2 		$718K Sell
29,260
-82,639
-74% -$2.08M ﹤0.01% 1498
2023
Q1 		$2.6M Sell
111,899
-225,049
-67% -$5.76M 0.01% 977
2022
Q4 		$8.53M Buy
336,948
+22,317
+7% +$547K 0.06% 458
2022
Q3 		$6.07M Buy
314,631
+86,797
+38% +$2.21M 0.05% 482
2022
Q2 		$5.8M Buy
227,834
+20,919
+10% +$488K 0.05% 474
2022
Q1 		$5.32M Buy
206,915
+97,076
+88% +$2.88M 0.04% 549
2021
Q4 		$4.6M Buy
109,839
+24,861
+29% +$974K 0.03% 673
2021
Q3 		$3.7M Buy
84,978
+22,376
+36% +$969K 0.03% 688
2021
Q2 		$2.96M Buy
+62,602
New +$2.85M 0.02% 784

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return